Atul Ltd 2014-15

105 ( ` cr) NOTE 13 NON-CURRENT INVESTMENTS 1 (continued) As at March 31, 2015 As at March 31, 2014 Long-term investments Face value 2 Number of shares c) Investments in Preference shares In subsidiary companies A tul Bioscience Ltd (6% Cumulative Redeemable Preference shares) 100 2,00,000 2.00 2.00 A tul Bioscience Ltd (10% Cumulative Redeemable Preference shares) 100 40,400 0.40 0.40 2.40 2.40 In associate company Amal Ltd (0% Redeemable Preference shares) (refer Note 28.13) 10 1,00,00,000 10.00 10.00 B. Other than trade investments a) Quoted Equity instruments In others Arvind Ltd 10 41,27,471 46.64 46.64 BASF India Ltd 10 2,61,396 0.84 0.84 ICICI Bank Ltd 10 19,823 0.14 0.14 Jain Irrigation Systems Ltd 2 4,200 0.02 0.02 Nagarjuna Oil Refinery Ltd 1 31,500 – – Novartis India Ltd 5 3,84,660 1.02 1.02 Pfizer Ltd 3 10 9,58,927 1.50 – Wyeth Ltd (upto December 11, 2014) 10 (13,69,895) – 1.50 50.16 50.16 b) Unquoted equity instruments In others N agarjuna Fertilizers and Chemicals Ltd 1 34,650 0.04 0.04 c) Investments in Government or Trust securities 6 Years National Savings Certificates (deposited with the Government departments) 88,000 0.01 0.01 148.31 136.47 C. Share application money (Atul Middle East FZ-LLC – subsidiary company) 0.51 – 148.82 136.47 Particulars Book value as at March 31, Market value as at March 31, 2015 2014 2015 2014 Quoted 50.20 50.20 376.99 236.15 Unquoted 98.11 86.27 148.31 136.47 Aggregate provision for diminution 2.54 2.52 1 Valued at cost unless otherwise stated | 2 In ` and fully paid unless otherwise stated | 3 Received upon merger of Wyeth Ltd Notes to the Financial Statements